Myeloid-Derived Suppressor Cells and CD68 + CD163 + M2-Like Macrophages as Therapeutic Response Biomarkers Are Associated with Plasma Inflammatory Cytokines: A Preliminary Study for Non-Small Cell Lung Cancer Patients in Radiotherapy.
Minghe LvXibing ZhuangShali ShaoXuan LiYunfeng ChengDuojiao WuXiangdong WangTiankui QiaoPublished in: Journal of immunology research (2022)
M2-like macrophages serve as therapeutic response biomarkers and are associated with the expressions of plasma inflammatory cytokines for NSCLC patients during radiotherapy.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- early stage
- chronic kidney disease
- small cell lung cancer
- peritoneal dialysis
- radiation therapy
- patient reported outcomes
- locally advanced
- advanced non small cell lung cancer
- signaling pathway
- patient reported
- epidermal growth factor receptor
- rectal cancer
- endoplasmic reticulum stress
- tyrosine kinase